The von Hippel–Lindau Protein, Vascular Endothelial Growth Factor, and Kidney Cancer

作者: Daniel J. George , William G. Kaelin

DOI: 10.1056/NEJMP030061

关键词:

摘要: Early in the 20th century, it was hypothesized that solid tumors secrete factors, now referred to as angiogenic induce angiogenesis — formation of new blood vessels thereby ensuring delivery enough support growth tumor. The idea inhibiting would have an antitumor effect has been borne out by startling anticancer activity some antiangiogenic agents tumor-bearing mice. For these reasons, perhaps no area cancer research attracted much attention, both on Main Street and Wall Street, angiogenesis. Unfortunately, dramatic effects . . .

参考文章(4)
James C. Yang, Leah Haworth, Richard M. Sherry, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Seth M. Steinberg, Helen X. Chen, Steven A. Rosenberg, A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer The New England Journal of Medicine. ,vol. 349, pp. 427- 434 ,(2003) , 10.1056/NEJMOA021491
D. E. Comings, A General Theory of Carcinogenesis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 70, pp. 3324- 3328 ,(1973) , 10.1073/PNAS.70.12.3324
Sharon E. Maynard, Jiang-Yong Min, Jaime Merchan, Kee-Hak Lim, Jianyi Li, Susanta Mondal, Towia A. Libermann, James P. Morgan, Frank W. Sellke, Isaac E. Stillman, Franklin H. Epstein, Vikas P. Sukhatme, S. Ananth Karumanchi, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia Journal of Clinical Investigation. ,vol. 111, pp. 649- 658 ,(2003) , 10.1172/JCI17189
A. G. Knudson, D. E. Anderson, Louise C Strong, Heredity and cancer in man. Progress in medical genetics. ,vol. 9, pp. 113- 158 ,(1973)